Correlation Between Tarsus Pharmaceuticals and Patterson UTI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Patterson UTI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Patterson UTI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Patterson UTI Energy, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Patterson UTI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Patterson UTI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Patterson UTI.

Diversification Opportunities for Tarsus Pharmaceuticals and Patterson UTI

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Tarsus and Patterson is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Patterson UTI Energy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Patterson UTI Energy and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Patterson UTI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Patterson UTI Energy has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Patterson UTI go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Patterson UTI

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.99 times more return on investment than Patterson UTI. However, Tarsus Pharmaceuticals is 1.01 times less risky than Patterson UTI. It trades about 0.14 of its potential returns per unit of risk. Patterson UTI Energy is currently generating about -0.14 per unit of risk. If you would invest  4,757  in Tarsus Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  351.00  from holding Tarsus Pharmaceuticals or generate 7.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Patterson UTI Energy

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Patterson UTI Energy 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Patterson UTI Energy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Patterson UTI is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Tarsus Pharmaceuticals and Patterson UTI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Patterson UTI

The main advantage of trading using opposite Tarsus Pharmaceuticals and Patterson UTI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Patterson UTI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Patterson UTI will offset losses from the drop in Patterson UTI's long position.
The idea behind Tarsus Pharmaceuticals and Patterson UTI Energy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules